SG103391G - Pharmaceutical formulations with controlled release of the active substance - Google Patents
Pharmaceutical formulations with controlled release of the active substanceInfo
- Publication number
- SG103391G SG103391G SG1033/91A SG103391A SG103391G SG 103391 G SG103391 G SG 103391G SG 1033/91 A SG1033/91 A SG 1033/91A SG 103391 A SG103391 A SG 103391A SG 103391 G SG103391 G SG 103391G
- Authority
- SG
- Singapore
- Prior art keywords
- active substance
- controlled release
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858524135A GB8524135D0 (en) | 1985-10-01 | 1985-10-01 | Darodipine compositions |
| GB858524653A GB8524653D0 (en) | 1985-10-07 | 1985-10-07 | Pharmaceutical formulations |
| GB858531419A GB8531419D0 (en) | 1985-12-20 | 1985-12-20 | Pindolol compositions |
| GB868603097A GB8603097D0 (en) | 1986-02-07 | 1986-02-07 | Pharmaceutical formulations |
| GB868605037A GB8605037D0 (en) | 1986-02-28 | 1986-02-28 | Oral pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG103391G true SG103391G (en) | 1992-01-17 |
Family
ID=27516617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1033/91A SG103391G (en) | 1985-10-01 | 1991-12-04 | Pharmaceutical formulations with controlled release of the active substance |
Country Status (20)
| Country | Link |
|---|---|
| KR (1) | KR920008817B1 (en) |
| AT (1) | AT402257B (en) |
| BE (1) | BE905516A (en) |
| CA (1) | CA1298784C (en) |
| CH (1) | CH669524A5 (en) |
| DE (1) | DE3632201C2 (en) |
| DK (1) | DK170016B1 (en) |
| ES (1) | ES2002508A6 (en) |
| FR (1) | FR2589732B1 (en) |
| GR (1) | GR862457B (en) |
| HK (1) | HK392A (en) |
| HU (1) | HU197201B (en) |
| IE (1) | IE59589B1 (en) |
| IL (1) | IL80182A (en) |
| LU (1) | LU86615A1 (en) |
| NL (1) | NL194822C (en) |
| NZ (1) | NZ217732A (en) |
| PT (1) | PT83456B (en) |
| SE (1) | SE503222C2 (en) |
| SG (1) | SG103391G (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440457B1 (en) | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| DE60229123D1 (en) * | 2001-02-20 | 2008-11-13 | Dinan Timothy Gerard | TREATMENT OF FIBROMYALGIA WITH PINDOLOL |
| TW200616681A (en) * | 2004-10-05 | 2006-06-01 | Recordati Ireland Ltd | Lercanidipine capsules |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
| CH639659A5 (en) * | 1978-12-18 | 1983-11-30 | Sandoz Ag | NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE. |
| DD145004A3 (en) * | 1978-09-25 | 1980-11-19 | Reinhard Huettenrauch | METHOD FOR PRODUCING SOLID A NOMENCLATES |
| CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
| JPS6056122B2 (en) * | 1980-05-21 | 1985-12-09 | 塩野義製薬株式会社 | sustained release formulation |
| GB2084017B (en) * | 1980-09-18 | 1984-08-22 | Sandoz Ltd | Pharmaceutical compositions effective against coronary heat disease and hypertension |
| US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| CA1208558A (en) * | 1982-10-07 | 1986-07-29 | Kazuo Kigasawa | Soft buccal |
| GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
| JPS61501511A (en) * | 1984-03-21 | 1986-07-24 | アメリカン・ホ−ム・プロダクツ・コ−ポレイション | sustained release pharmaceutical capsules |
| JPS6124516A (en) * | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | Long active tablet |
-
1986
- 1986-09-19 HU HU864004A patent/HU197201B/en unknown
- 1986-09-19 NL NL8602370A patent/NL194822C/en not_active IP Right Cessation
- 1986-09-22 CH CH3780/86A patent/CH669524A5/de not_active IP Right Cessation
- 1986-09-23 DE DE3632201A patent/DE3632201C2/en not_active Expired - Lifetime
- 1986-09-29 GR GR862457A patent/GR862457B/en unknown
- 1986-09-29 NZ NZ217732A patent/NZ217732A/en unknown
- 1986-09-29 CA CA000519302A patent/CA1298784C/en not_active Expired - Lifetime
- 1986-09-29 KR KR1019860008136A patent/KR920008817B1/en not_active IP Right Cessation
- 1986-09-29 SE SE8604112A patent/SE503222C2/en not_active IP Right Cessation
- 1986-09-29 IL IL80182A patent/IL80182A/en not_active IP Right Cessation
- 1986-09-29 IE IE256586A patent/IE59589B1/en not_active IP Right Cessation
- 1986-09-29 DK DK464686A patent/DK170016B1/en not_active IP Right Cessation
- 1986-09-29 PT PT83456A patent/PT83456B/en unknown
- 1986-09-30 ES ES8602313A patent/ES2002508A6/en not_active Expired
- 1986-09-30 LU LU86615A patent/LU86615A1/en unknown
- 1986-09-30 AT AT0260486A patent/AT402257B/en not_active IP Right Cessation
- 1986-09-30 BE BE1/011554A patent/BE905516A/en not_active IP Right Cessation
- 1986-10-01 FR FR868613668A patent/FR2589732B1/en not_active Expired
-
1991
- 1991-12-04 SG SG1033/91A patent/SG103391G/en unknown
-
1992
- 1992-01-02 HK HK3/92A patent/HK392A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NL194822B (en) | 2002-12-02 |
| HK392A (en) | 1992-01-10 |
| ATA260486A (en) | 1996-08-15 |
| KR920008817B1 (en) | 1992-10-09 |
| ES2002508A6 (en) | 1988-08-16 |
| DE3632201A1 (en) | 1987-04-02 |
| IL80182A (en) | 1991-01-31 |
| FR2589732A1 (en) | 1987-05-15 |
| HUT44701A (en) | 1988-04-28 |
| NL8602370A (en) | 1987-05-04 |
| IE59589B1 (en) | 1994-03-09 |
| FR2589732B1 (en) | 1989-07-13 |
| DK170016B1 (en) | 1995-05-01 |
| NL194822C (en) | 2003-04-03 |
| GR862457B (en) | 1987-01-29 |
| CA1298784C (en) | 1992-04-14 |
| DK464686D0 (en) | 1986-09-29 |
| DE3632201C2 (en) | 1997-05-07 |
| BE905516A (en) | 1987-03-30 |
| DK464686A (en) | 1987-04-02 |
| AT402257B (en) | 1997-03-25 |
| IL80182A0 (en) | 1986-12-31 |
| PT83456B (en) | 1989-05-12 |
| HU197201B (en) | 1989-03-28 |
| SE8604112L (en) | 1987-04-02 |
| IE862565L (en) | 1987-04-01 |
| NZ217732A (en) | 1990-07-26 |
| SE8604112D0 (en) | 1986-09-29 |
| PT83456A (en) | 1986-10-01 |
| LU86615A1 (en) | 1987-04-02 |
| KR870003777A (en) | 1987-05-04 |
| SE503222C2 (en) | 1996-04-22 |
| CH669524A5 (en) | 1989-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0224146A3 (en) | Pharmaceutical preparation for the controlled release of active ingredients | |
| GB2211413B (en) | Pharmaceutical formulations comprising microcapsules | |
| EP0282951A3 (en) | Controlled release preparations of active materials | |
| GB8502974D0 (en) | Sustained release of active substance | |
| GB8504099D0 (en) | Physiologically active substances | |
| GB8630870D0 (en) | Active support substance | |
| ZA853462B (en) | Controlled release pharmaceutical preparations | |
| IL74049A0 (en) | Controlled release liquid dosage pharmaceutical formulations | |
| NO862373D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIENOPYRIDONES. | |
| GB2181053B (en) | Pharmaceutical formulations with controlled release of the active substance | |
| IL79163A0 (en) | 1,8-bridged 4-quinolone-3-carboxylic acids,their preparation,medicaments containing them and their use for the preparation of medicaments | |
| GB2190287B (en) | Controlled release ketoprofen pharmaceutical formulation | |
| GR862457B (en) | Pharmaceutical formulations with controlled release of the active substance | |
| HUT42679A (en) | Insecticidal and acaricidal compositions comprising alkanoyl-anilide derivatives as active substance and process for preparing the active substances | |
| GB8801863D0 (en) | Pharmaceutical formulations with controlled drug release | |
| ZA867507B (en) | Pharmaceutical formulations with controlled release of the active substance | |
| AU6322686A (en) | Pharmaceutical formulations with controlled release of the active substance | |
| ZA86705B (en) | Controlled release insecticide | |
| ZA875937B (en) | Pharmaceutical formulations comprising microcapsules | |
| IE850071L (en) | Controlled release pharmaceutical formulations | |
| GB8603031D0 (en) | Pharmaceutical formulations | |
| IT8648494A0 (en) | PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE OF THE ACTIVE SUBSTANCE | |
| HUT43925A (en) | Insecticides comprising trihalogen-imidazole derivatives as active substance and process for preparing the active substances | |
| EG17797A (en) | Controlled release formulation | |
| IL68779A0 (en) | Pharmaceutical mixture with controlled release of active substance |